USD
+$0.00
(+0.00%
)At Close (As of Sep 15, 2025)
$97.37M
Market Cap
-
P/E Ratio
-0.25
EPS
$3.42
52 Week High
$0.80
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | - |
Total Revenue | $0 |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$8.3M |
Selling General And Administrative | $4.8M |
Research And Development | $3.5M |
Operating Expenses | $8.3M |
Investment Income Net | - |
Net Interest Income | $98K |
Interest Income | $249K |
Interest Expense | $151K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $258K |
Income Before Tax | -$8.2M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$8.2M |
Comprehensive Income Net Of Tax | - |
Ebit | -$8.3M |
Ebitda | -$8.1M |
Net Income | -$8.2M |
Field | Value (USD) |
---|---|
Total Assets | $4.1M |
Total Current Assets | $3.5M |
Cash And Cash Equivalents At Carrying Value | $3.1M |
Cash And Short Term Investments | $3.1M |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $565K |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $414K |
Other Non Current Assets | - |
Total Liabilities | $261K |
Total Current Liabilities | $261K |
Current Accounts Payable | $156K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | - |
Total Non Current Liabilities | $0 |
Capital Lease Obligations | - |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | - |
Other Current Liabilities | $104K |
Other Non Current Liabilities | - |
Total Shareholder Equity | $3.8M |
Treasury Stock | - |
Retained Earnings | -$65M |
Common Stock | $26K |
Common Stock Shares Outstanding | $26M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$8.1M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $151K |
Capital Expenditures | $0 |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | - |
Cashflow From Financing | -$62K |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$8.2M |
Field | Value (USD) |
---|---|
Gross Profit | - |
Total Revenue | $0 |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$8.3M |
Selling General And Administrative | $4.8M |
Research And Development | $3.5M |
Operating Expenses | $8.3M |
Investment Income Net | - |
Net Interest Income | $98K |
Interest Income | $249K |
Interest Expense | $151K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $258K |
Income Before Tax | -$8.2M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$8.2M |
Comprehensive Income Net Of Tax | - |
Ebit | -$8.3M |
Ebitda | -$8.1M |
Net Income | -$8.2M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients suffering from cannabinoid overdose and addiction. The company is headquartered in Lakeway, Texas.